New study reveals potential targets to treat progressive supranuclear palsy
An MBI research team has discovered a molecular mechanism driving a toxic buildup of the protein tau in PSP.
An MBI research team has discovered a molecular mechanism driving a toxic buildup of the protein tau in PSP.
Alzheimer’s and progressive supranuclear palsy, or PSP, show similar gene expression changes in distinct brain regions.